495 related articles for article (PubMed ID: 27551429)
1. Efficacy of varicella (VZV) vaccination: an update for the clinician.
Wang L; Zhu L; Zhu H
Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
[TBL] [Abstract][Full Text] [Related]
2. Animal models of varicella zoster virus infection.
Haberthur K; Messaoudi I
Pathogens; 2013 May; 2(2):364-82. PubMed ID: 25437040
[TBL] [Abstract][Full Text] [Related]
3. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
4. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
8. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
Freer G; Pistello M
New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
[TBL] [Abstract][Full Text] [Related]
10. Prevention of shingles: safety and efficacy of live zoster vaccine.
Quan D; Cohrs RJ; Mahalingam R; Gilden DH
Ther Clin Risk Manag; 2007 Aug; 3(4):633-9. PubMed ID: 18472986
[TBL] [Abstract][Full Text] [Related]
11. Varicella and herpes zoster vaccine development: lessons learned.
Warren-Gash C; Forbes H; Breuer J
Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster virus vaccines: potential complications and possible improvements.
Silver B; Zhu H
Virol Sin; 2014 Oct; 29(5):265-73. PubMed ID: 25358998
[TBL] [Abstract][Full Text] [Related]
14. Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.
Wang L; Verschuuren EAM; van Leer-Buter CC; Bakker SJL; de Joode AAE; Westra J; Bos NA
Front Immunol; 2018; 9():1632. PubMed ID: 30079064
[TBL] [Abstract][Full Text] [Related]
15. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections.
Andrei G; Snoeck R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672709
[TBL] [Abstract][Full Text] [Related]
16. A novel vaccine (Zostavax) to prevent herpes zoster.
Holcomb K; Weinberg JM
G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
Li J; Fu L; Yang Y; Wang G; Zhao A
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
[TBL] [Abstract][Full Text] [Related]
18. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
Harbecke R; Jensen NJ; Depledge DP; Johnson GR; Ashbaugh ME; Schmid DS; Breuer J; Levin MJ; Oxman MN
Vaccine; 2020 Jan; 38(2):150-157. PubMed ID: 31679866
[TBL] [Abstract][Full Text] [Related]
19. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
20. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
